Cardiovascular System
Cardiovascular System
UrospirTM Spironolactone Oral Solution
UrospirTM Spironolactone Oral Solution is a potassium sparing diuretic.
UrospirTM Spironolactone Oral Solution is indicated for:
-
- Congestive cardiac failure
- Hepatic cirrhosis with ascites and oedema
- Malignant ascites
- Nephrotic syndrome
- Diagnosis and treatment of primary aldosteronism.
Cardiovascular System
Urospir<sup>TM</sup> Spironolactone Oral Solution
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
